Study on managing newborn infection risk with a calculator
Part of Genetic & congenital, Infections clinical trials.
This trial tests whether a new calculator helps doctors decide the best care for newborns at risk of early infection. It looks at babies born at 35 weeks or later who had a blood test for infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born at Hillel Yaffe Medical Center.
- Your baby is at least 35 weeks into pregnancy (full-term or close to it).
- A blood culture (test for infection in the blood) was taken from your baby.
- Your baby is not being checked for infection for any other reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether an electronic “resistance calculator” helps clinicians choose antibiotics for adults hospitalized with suspected sepsis. It compares outcomes when hospitals use the tool versus usual practice to see if antibiotic decisions improve care.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study is testing a new blood test (called presepsin) to see if it can help doctors quickly diagnose sepsis (a serious infection) in newborns. If your baby has signs of infection, this test might help find the cause sooner.
This study looks at how blood markers like lactate and complete blood count (CBC) can help spot infection in newborns up to 28 days old. It may lead to faster, more accurate diagnosis for babies with possible sepsis.
Hear when a new Neonatal Early-onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.